One study which utilized using viral DNA to deliver the TYMP gene to the liver reduced thymidine and deoxyuridine levels to normal levels in about half of the mice studied, showing potential that gene therapy can treat MNGIE [8]. Here, TYMP is linked to mitochondrial neurogastrointestinal encephalomyopathy.